Search by Drug Name or NDC
NDC 63824-0445-40 Clearasil Active Lightweight Face and Body 2 g/100mL Details
Clearasil Active Lightweight Face and Body 2 g/100mL
Clearasil Active Lightweight Face and Body is a TOPICAL LOTION in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is SALICYLIC ACID.
MedlinePlus Drug Summary
Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or birthmarks. Salicylic acid is in a class of medications called keratolytic agents. Topical salicylic acid treats acne by reducing swelling and redness and unplugging blocked skin pores to allow pimples to shrink. It treats other skin conditions by softening and loosening dry, scaly, or thickened skin so that it falls off or can be removed easily.
Related Packages: 63824-0445-40Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Salicylic Acid Topical
Product Information
| NDC | 63824-0445 |
|---|---|
| Product ID | 63824-445_18350dc0-3b12-4637-8ec2-e7d5696c870c |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Clearasil Active Lightweight Face and Body |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Salicylic Acid |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LOTION |
| Route | TOPICAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | g/100mL |
| Substance Name | SALICYLIC ACID |
| Labeler Name | RB Health (US) LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part333D |
| Listing Certified Through | 2023-12-31 |
Package
Package Images
NDC 63824-0445-40 (63824044540)
| NDC Package Code | 63824-445-40 |
|---|---|
| Billing NDC | 63824044540 |
| Package | 118 mL in 1 TUBE (63824-445-40) |
| Marketing Start Date | 2018-09-10 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 7ef19e60-9ce1-44f2-a8f0-7eb851b6f2cd Details
Warnings
For external use only
When using this product
- avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water.
- skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
- limit use to the face, neck, chest and back
Directions
- clean the skin thoroughly before applying this product
- cover the entire affected area with a thin layer one to three times daily
- because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
- if bothersome dryness or peeling occurs, reduce application to once a day or every other day
Inactive ingredients
water, butylene glycol, octyldodecanol, steareth-2, cetyl alcohol, steareth-21, dimethicone, polyacrylamide, glycerin, C13-14 isoparaffin, sodium hydroxide, xanthan gum, magnesium aluminum silicate, laureth-7, fragrance, lavandula stoechas extract, helichrysum italicum extract, cistus monspeliensis extract, titanium dioxide
SPL UNCLASSIFIED SECTION
PRINCIPAL DISPLAY PANEL - 118 mL Tube Label
INGREDIENTS AND APPEARANCE
| CLEARASIL ACTIVE LIGHTWEIGHT FACE AND BODY
salicylic acid lotion |
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
| Labeler - RB Health (US) LLC (081049410) |